Search Results - "WOLOSZCZUK, W"

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide by Polyzos, S. A., Anastasilakis, A. D., Bratengeier, C., Woloszczuk, W., Papatheodorou, A., Terpos, E.

“…Summary Sclerostin is expressed by osteocytes and inhibits bone formation by osteoblasts. In this study, serum sclerostin was positively correlated with either…”
Get full text

Serum levels of osteoprotegerin increase with age in a healthy adult population by Kudlacek, S, Schneider, B, Woloszczuk, W, Pietschmann, P, Willvonseder, R

“…Regulation of the balance of osteoblastic and osteoclastic activity is critical for the understanding of normal cell biology and forms the basis of metabolic…”
Get full text

Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone by Piemonte, S., Romagnoli, E., Bratengeier, C., Woloszczuk, W., Tancredi, A., Pepe, J., Cipriani, C., Minisola, S.

“…Objective: This study was carried out in order to evaluate the effect of 18-month treatment with PTH (1–34) or PTH (1–84) on serum sclerostin levels in humans…”
Get full text

Changes of circulating sclerostin levels after different kinds of physical exercise with high impact on musculoskeletal system in healthy young females by Haschka, J, Kocijan, R, Muschitz, C, Patsch, J.M, Bittighofer, C, Trubrich, A, Woloszczuk, W, Dinu, S, Kapiotis, S, Resch, H

Get full text

Assessment of vitamin D and calcium status in healthy adult Austrians by Kudlacek, S., Schneider, B., Peterlik, M., Leb, G., Klaushofer, K., Weber, K., Woloszczuk, W., Willvonseder, R.

“…Background Because there is reason to assume that also in Austria calcium and vitamin D malnutrition is wide‐spread, we initiated a comprehensive study on…”
Get full text

Circulating serum sclerostin levels in healthy young women after different kinds of physical load by Haschka, J, Woloszczuk, W, Kocijan, R, Muschitz, C, Bittighofer, C, Trubrich, A, Dinu, S, Kapiotis, S, Resch, H

Get full text

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women — The six-month effect of risedronate and teriparatide by Polyzos, S.A, Anastasilakis, A.D, Bratengeier, C, Woloszczuk, W, Papatheodorou, A, Terpos, E

Get full text

Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis by SKOUMAL, M, KOLARZ, G, HABERHAUER, G, WOLOSZCZUK, W, HAWA, G, KLINGLER, A

“…We examined OPG and soluble RANKL in the serum (sOPG, sRANKL) and synovial fluid (synOPG, synRANKL) in patients with rheumatoid arthritis (RA) and…”
Get full text

Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure by Hülsmann, M., Berger, R., Sturm, B., Bojic, A., Woloszczuk, W., Bergler-Klein, J., Pacher, R.

“…Aims To compare the precursor of atrial and brain natriuretic peptide (N-ANP, N-BNP), brain natriuretic peptide (BNP), big endothelin-1, the 6-min walk test…”
Get full text

Dickkopf-1 and sclerostin in different phases of multiple myeloma; The effect of lenalidomide and dexamethasone treatment with or without bortezomib by Terpos, E, Christoulas, D, Gkotzamanidou, M, Bratengeier, C, Gavriatopoulou, M, Woloszczuk, W, Kastritis, E, Dimopoulos, M.A

Get full text

Serum sclerostin levels decline in postmenopausal women with osteoporosis following treatment with intermittent PTH by Piemonte, S, Romagnoli, E, Pepe, J, Del Fiacco, R, Cipriani, C, Bratengeier, C, Woloszczuk, W, Tancredi, A, Minisola, S

Get full text

Serum osteoprotegerin but not receptor activator of NF-κB ligand correlates with Larsen score in rheumatoid arthritis by Skoumal, M, Kolarz, G, Woloszczuk, W, Hawa, G, Klingler, A

Get full text

Serum levels of cathepsin K decrease with age in both women and men by Kerschan-Schindl, K., Hawa, G., Kudlacek, S., Woloszczuk, W., Pietschmann, P.

“…Bone turnover increases with age. In a previous study, we reported on bone metabolism in young and elderly women and men. The aim of the present investigation…”
Get full text

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases by Franz, Martina, Woloszczuk, Wolfgang, Hörl, Walter H.

“…Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Biologically active N-terminal…”
Get full text

Normative data of bone mineral density in an unselected adult Austrian population by Kudlacek, S., Schneider, B., Peterlik, M., Leb, G., Klaushofer, K., Weber, K., Woloszczuk, W., Willvonseder, R.

“…Background There is increasing evidence that correct interpretation of bone mineral density (BMD) measurements by dual energy X‐ray absorptiometry (DEXA)…”
Get full text

Bone turnover markers and sex hormones in men with idiopathic osteoporosis by Pietschmann, P., Kudlacek, S., Grisar, J., Spitzauer, S., Woloszczuk, W., Willvonseder, R., Peterlik, M.

“…Background In contrast to osteoporosis in postmenopausal women, osteoporosis in men has received much less attention. Patients and We determined various…”
Get full text

Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus by Redlich, Kurt, Ziegler, Sophie, Kiener, Hans P, Spitzauer, Susanne, Stohlawetz, Petra, Bernecker, Peter, Kainberger, Franz, Grampp, Stephan, Kudlacek, Stefan, Woloszczuk, Wolfgang, Smolen, Josef S, Pietschmann, Peter

“…OBJECTIVE To evaluate bone mineral density and biochemical parameters of bone metabolism in ambulatory premenopausal female patients with systemic lupus…”
Get full text

Receptor activator of nuclear factor κB ligand and osteoprotegerin in men with thyroid cancer by Mikosch, P., Igerc, I., Kudlacek, S., Woloszczuk, W., Gallowitsch, H. J., Kresnik, E., Stettner, H., Grimm, G., Lind, P., Pietschmann, P.

“…Background  Suppressive thyroid hormone therapy is generally a lifelong treatment for patients with differentiated thyroid cancer (DTC). However, long‐standing…”
Get full text

Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables by Koller-Strametz, J, Pacher, R, Frey, B, Kos, T, Woloszczuk, W, Stanek, B

“…The cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) are increased in the circulation of patients with chronic heart failure…”
Get more information

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans by HARTTER, E, SVOBODA, T, LUDVIK, B, SCHULLER, M, LELL, B, KUENBURG, E, BRUNNBAUER, M, WOLOSZCZUK, W, PRAGER, R

“…Amylin is a 37-amino acid pancreatic polypeptide, probably involved in the pathophysiology of Type 2 (non-insulin-dependent) diabetes mellitus. We have…”
Get full text